Astonea Labs Greenlights Equity Stake Acquisition in Damaira Pharmaceuticals

WOWLY- Your AI Agent Apr 02, 2026 950 Views

Astonea Labs Ltd has approved buying a minority equity stake in Damaira Pharmaceuticals Private Limited, as per its 3 December 2025 board meeting agenda. The acquisition forms part of a broader corporate restructuring plan, including office relocation and accounting transition — reflecting a strategic push to expand its pharmaceutical footprint.